Cancer Systemic Therapy Policy Committee

 

This advisory committee provides the Nova Scotia Department of Health with advice on what cancer drugs should qualify for public funding. The committee is made up of 23 people, including cancer specialists, a cancer survivor, a pharmacist, ethicist other health care providers and members from the Department of Health.

The committee reviews cancer drugs using a values and evidence-based decision making framework. The framework is used to guide discussions around the economics, ethics, and evidence to make recommendations to the Deputy Minister of Health about additions, changes, and deletions to the cancer drug formulary.

• Terms of Reference (PDF)
• Decision Making Framework (PDF)
• Appeal Process (PDF)
• Appeal Form (PDF)

 

Record of Recommendations

 

 

• Alemtuzumab (Mab Campath ®)
  • Guideline for use in Chronic Lymphocytic Leukemia (CLL) (PDF)
  • Record of Recommendation in Chronic Lymphocytic Leukemia (CLL) (PDF)

 

• Bevacizumab (Avastin ®)
  • Record of Recommendation in Colorectal Cancer (PDF)
  • Guidelines for the Role of Bevacizumab (Avastin®) in Metastatic Colorectal Cancer (MCRC) (PDF)

   

• Bortezomib (Velcade ®)
  • Guideline for use in Multiple Myeloma (PDF)
  • Record of Recommendation in Multiple Myeloma (PDF)

 

• Dasatinib (Sprycel ®)
  • Guideline for use in CML & ALL (PDF)
  • Record of Recommendation in MM & ALL (PDF)

 

• Oxaliplatin (Eloxatin ®)
• Guideline for the Adjuvant use in Colon Cancer (PDF)
• Guideline for the use in Metastatic Colorectal Cancer (PDF)
• Record of Recommendation for the Adjuvant use in Colon Cancer (PDF)
• Record of Recommendation for the use in Metastatic Colorectal Cancer (PDF)

 

• Pemetrexed (Alimta ®)
  • Guideline for use in Non-Small Cell Lung Cancer (NSCLC) (PDF)
  • Record of Recommendation in Non-Small Cell Lung Cancer (NSCLC) (PDF)
    
    
    
• Rituximab (Rituxan ®)
• Guideline for the Maintenance Therapy of NHL (PDF)
• Guideline for the Treatment of NHL (PDF)
• Record of Recommendation as Maintenance Therapy for NHL (PDF)
• Record of Recommendation for the Treatment of NHL (PDF)

 

• Sorafenib (Nexavar ®)
  • Guideline for the use in Renal Cell Carcinoma (RCC) (PDF)
  • Record of Recommendation in RCC (PDF)

 

• Sunitinib (Sutent ®)
  • Guideline for the use in RCC (PDF)
  • Guideline for use in the treatment of GIST (PDF)
  • Record of Recommendation for GIST (PDF)
  • Record of Recommendation for RCC (PDF)

 

• Trastuzumab (Herceptin ®)
  • Guideline for use in Adjuvant Breast Cancer (PDF)